20 Pageviews Read Stories
- EIN 46-3673346
- (212) 327-8371
- 1300 York Ave New York NY 10065-4805 USA
- http://tritdi.org
- Add to Favorites
Nonprofit Overview
Causes: Health, Medical Research
Mission: The tri-institutional therapeutics discovery institute, inc. Was organized and is operated as an independent, non-profit corporation, controlled by leading not-for-profit academic, medical and research institutions, to further and improve health and the diagnosis, prevention and treatment of disease through futhering and improving translational research, generate innovative proof-of-concept studies, and advance the scientific activities of the controlling institutions' (memorial sloan kettering cancer center, the rockefeller university and weil cornell medical college)faculty, fellows and students in aspects of translational research, chemistry, pharmacology, and drug discovery.
Programs: The tri-institutional therapeutics discovery institute, a partnership among three world-renowned scientific and medical institutions, works to more effectively develop therapeutics that arise from discoveries made in basic science labs. With a focus on early-stage drug discovery, the institute provides expertise in medicinal chemistry and compound screening, and conducts proof of concept studies needed to demonstrate that drug candidates can successfully alter the course of a disease.
the institute works to provide high-quality opportunities for training students and post-doctoral fellows, to deepen faculty involvement in drug discovery, and to support translational research by leveraging the expertise of all three academic institutions and industry partners.
the institute facilitates more efficient sharing of core facilities between the three partner institutions and forms industry partnerships with pharmaceutical and biotech companies to further advance drug research. It seeks to create intellectual property that can be further developed by an open field of industry collaborators.